Skip to main content
CSPC Pharmaceutical Group Limited logo

CSPC Pharmaceutical Group Limited — Investor Relations & Filings

Ticker · 1093 ISIN · US12591J1088 LEI · 529900M3XQCW234H8O91 HKEX Manufacturing
Open in API
Filings indexed 1,526 across all filing types
Latest filing 2014-03-24 Annual Report
Country HK Hong Kong
Listing HKEX 1093

About CSPC Pharmaceutical Group Limited

https://www.cspc.com.hk/en/global/home.…

CSPC Pharmaceutical Group Limited is a comprehensive enterprise specializing in the research, development, manufacturing, and sale of pharmaceutical products. The company operates across two main segments: finished drugs and bulk drugs. It emphasizes innovation and new drug development, evidenced by substantial R&D investment, to produce high-quality, effective, and reliable medicines. Its portfolio includes key innovative products such as NBP (soft capsules and injections), Oulaining, and Enxi, which are among its top-selling drugs.

Recent filings

Filing Released Lang Actions
ANNOUNCEMENT OF ANNUAL RESULTS FOR THE YEAR ENDED 31 DECEMBER 2013
Annual Report Classification · 95% confidence The document is titled 'ANNOUNCEMENT OF ANNUAL RESULTS FOR THE YEAR ENDED 31 DECEMBER 2013' and contains detailed financial statements including consolidated statements of profit or loss, comprehensive income, and financial position for the full fiscal year ended December 31, 2013. It includes management discussion such as Chairman's statement, business overview, outlook, and notes on accounting standards applied. The length is substantial (15,000 characters) and contains actual financial data and analysis, not just a summary or announcement of a report. This matches the characteristics of an Annual Report (10-K equivalent) rather than a brief earnings release or announcement. Therefore, the document should be classified as an Annual Report (10-K). FY 2013
2014-03-24 English
LIST OF DIRECTORS AND THEIR ROLE AND FUNCTION
Board/Management Information Classification · 95% confidence The document lists the members of the board of directors, their roles, and committee memberships. It focuses on governance structure and board composition without financial data or other report content. This matches the description of Board/Management Information (MANG), which covers announcements of changes or details about the company's board or senior management. The document is short and does not contain financial statements or other report types. Therefore, the correct classification is MANG with high confidence.
2014-03-19 English
RESIGNATION OF INDEPENDENT NON-EXECUTIVE DIRECTOR AND RULE 3.10A OF THE LISTING RULES
Board/Management Information Classification · 100% confidence The document is an announcement regarding the resignation of an independent non-executive director and compliance with a listing rule requiring a minimum number of independent directors. It discusses board composition changes and efforts to find a replacement. There are no financial statements, earnings data, or detailed management discussion. The content focuses on board/management changes, specifically a director resignation and board composition compliance. The document length is 3596 characters, which is relatively short and typical for a management change announcement. Therefore, the document fits best under Board/Management Information (MANG).
2014-03-19 English
DATE OF BOARD MEETING
Regulatory Filings Classification · 95% confidence The document is a short announcement from CSPC Pharmaceutical Group Limited stating the date of a board meeting to approve final results for the year ended 31 December 2013 and to consider a final dividend. It does not contain any financial data or detailed report content but merely announces the upcoming board meeting and its agenda. The length is only 1377 characters, which is quite short and fits the pattern of an announcement rather than a full report. According to the rules, such short announcements about meetings to approve results are best classified as Regulatory Filings (RNS), since it is a general regulatory announcement and does not contain the actual financial report or detailed results.
2014-03-12 English
Monthly return of equity issuer on movements in securities for the month ended 28 February 2014
Share Issue/Capital Change Classification · 95% confidence The document is titled 'Monthly Return of Equity Issuer on Movements in Securities' for the month ended 28/2/2014, submitted to the Hong Kong Exchanges and Clearing Limited. It details movements in authorized share capital, issued share capital, share options, warrants, convertibles, and other share-related activities. The content focuses on share capital changes and securities movements rather than financial performance, earnings, or management commentary. It is a regulatory filing reporting share capital movements for a specific month, typical of a Major Shareholding Notification or Share Issue/Capital Change. However, since it reports monthly movements in securities and share capital without announcing a new share issue or capital change event per se, it aligns best with Major Shareholding Notification (MRQ) or Share Issue/Capital Change (SHA). Given the detailed monthly movements in securities and share capital, the document fits the Share Issue/Capital Change (SHA) category, which covers announcements regarding new share issues, stock splits, or other capital changes. The document length is substantial (over 14,000 characters), indicating it is the report itself, not just an announcement of a report. Therefore, the classification is SHA with high confidence.
2014-03-04 English
Monthly return of equity issuer on movements in securities for the month ended 31 January 2014
Regulatory Filings Classification · 95% confidence The document is titled 'Monthly Return of Equity Issuer on Movements in Securities' for the month ended 31/1/2014, submitted to the Hong Kong Exchanges and Clearing Limited. It details movements in authorized share capital, issued share capital, share options, warrants, convertibles, and other share-related activities. The content is focused on share capital changes and securities movements rather than financial performance, earnings, or management commentary. It is a regulatory filing reporting monthly share capital movements, typical for compliance with exchange rules. It is not an annual or interim report, earnings release, or management discussion. The document is substantive and detailed, not a brief announcement or certification. Therefore, it fits best under Regulatory Filings (RNS), which covers general regulatory announcements and compliance documents that do not fit other specific categories.
2014-02-05 English

Browse filings by year

28 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.